ARCHIVES

Cooperative Group Chairman Unhappy Over Exclusion From Funding at Recommended Levels

This article is from The Cancer Letter archive.

Vol. 09 No. 46 | December 2, 1983

Download PDF Visit The Full Archive

Related Articles

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

DCPC advisors OK 16 Year Trial Of Screening Methods

February 15, 1991

ORI Finds St. Mary’s Data Managers Falsified Data In BCPT

September 8, 1995

Cancer Panel To Form Committee On Breast Cancer

October 11, 1991

Cancer “Report Card”: Growing Population Of Cancer Survivors Creates Need For New Research Emphasis, NCI Director Says

March 20, 1998